-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Akari Therapeutics Plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q2 2024.
- Akari Therapeutics Plc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
- Akari Therapeutics Plc annual Share-based Payment Arrangement, Expense for 2023 was $275K, a 50.8% decline from 2022.
- Akari Therapeutics Plc annual Share-based Payment Arrangement, Expense for 2022 was $560K, a 78% increase from 2021.
- Akari Therapeutics Plc annual Share-based Payment Arrangement, Expense for 2021 was $315K, a 3.34% decline from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)